RxSight, Inc.
RXST
$5.55
$0.030.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.26% | 7.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.26% | 7.48% | |||
| Cost of Revenue | 0.68% | 20.15% | |||
| Gross Profit | -6.99% | 4.28% | |||
| SG&A Expenses | 15.00% | 1.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.87% | 3.36% | |||
| Operating Income | -57.26% | 6.91% | |||
| Income Before Tax | -73.59% | 6.72% | |||
| Income Tax Expenses | 20.00% | -50.00% | |||
| Earnings from Continuing Operations | -73.56% | 6.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -73.56% | 6.76% | |||
| EBIT | -57.26% | 6.91% | |||
| EBITDA | -62.07% | 7.40% | |||
| EPS Basic | -72.96% | 7.22% | |||
| Normalized Basic EPS | -73.05% | 7.22% | |||
| EPS Diluted | -72.96% | 7.22% | |||
| Normalized Diluted EPS | -73.05% | 7.22% | |||
| Average Basic Shares Outstanding | 0.32% | 0.51% | |||
| Average Diluted Shares Outstanding | 0.32% | 0.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||